Can serum ferritin level predict disease severity in patients with Crimean-Congo hemorrhagic fever?;Kırım-kongo kanamalı ateşi olan hastalarda serum ferritin düzeyleri ile hastalık şiddeti tahmin edilebilir mi?

Eurasian Journal of Medicine

Volumn 45, Issue 2, 2013, Pages 108-114

  Metanat, Maliheh ^a   Sharifi Mood, Batool ^a   Tabatabaei, Mehdi ^a   Sarraf Shirazi, Mohammad ^a  

^a ZAHEDAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Crimean congo hemorrhagic fever; Disease severity; Fer ritin

Indexed keywords

EID: 84879175125     PISSN: 13088734     EISSN: 13088742     Source Type: Journal    
DOI: 10.5152/eajm.2013.22     Document Type: Article

References (29)

1. Tekin S, Bursali A, Mutluay N, Keskin A, Dundar E. Crimean-Congo hemorrhagic fever virus in various ixodid tick species from a highly endemic area. Vet Parasitol 2012; 186: 546-552.
2. Sharifi-Mood B, Alavi-Naini R, Metanat M. Ten years after the beginning of the Crimean-Congo Haemorrhagic Fever outbreak in Iran: A promising report. Iranian Journal of Clinical Infectious Diseases 2009; 4: 189-119.
3. Mehrabi-Tavana A, Chinikar S, Mazaheri V. The seroepidemio-logical aspects of Crimean-Congo hemorrhagic fever in three healthcare workers: a report from Iran. Arch Iranian Med 2002; 5: 255-258.
4. Alavi-Naini R, Moghtaderi A, Koohpayeh HR, et al. Crimean-Congo hemorrhagic fever in Southeast of Iran. J Infect 2006; 52: 378-382.
5. Mardani M, Keshtkar-Jahromi M. Crimean-Congo hemorrhagic fever. Arch Iran Med 2007; 10: 204-214.
6. Sisman A. Epidemiologic features and risk factors of Crimean-Congo hemorrhagic fever in Samsun province, Turkey. J Epidemiol 2013; 23: 95-102.
7. Metanat M, Sharifi-Mood B, Salehi M, Alavi-Naini R. Clinical outcomes in Crimean-Congo hemorrhagic fever: A five-years experience in the treatment of patients in oral Ribavirin. Int J Virol 2006; 2: 21-24.
8. Ergonul O, Tuncbilek S, Baykam N, Celikbas A, Dokuzoguz B. Evaluation of serum levels of interleukin (IL)-6, IL-10, and tumor necrosis factor-alpha in patients with Crimean-Congo hemorr-hagic fever. J Infect Dis 2006; 193: 941-944.
9. Onguru P, Dagdas S, Bodur H, et al. Coagulopathy parameters in patients with Crimean-Congo hemorrhagic fever and its relation with mortality. J Clin Lab Anal 2010; 24: 163-166.
10. Ergonul, O, Çelikbas A, Baykam N, Eren S, Dokuzoguz B. Analysis of risk factors among patients with Crimean - Congo hemorrha-gic fever virus infection: severity criteria revisited. Clin Microbiol Infect 2006; 12: 551-554.
11. Cevik MA, Erbay A, Bodur H, et al. Clinical and laboratory features of Crimean-Congo hemorrhagic fever: predictors of fatality. Int J Infect Dis 2008: 12; 374-379.
12. Yilmaza G, Koksal I, Topbas M, Yilmaz H, Aksoy F. The effectiveness of routine laboratory findings in determining disease severity in patients with Crimean-congo hemorrhagic fever: severity prediction criteria. Journal of clinical virology. 2010; 47: 361-365.
13. Cevik MA, Erbay A, Bodur H, et al. Viral load as a predictor of outcome in Crimean-Congo hemorrhagic fever. Clin Infect Dis 2007; 45: 96-100.
14. Duh D, Saksida A, Petrovec M, et al. Viral load as predictor of Crimean-Congo hemorrhagic fever outcome. Emerg Infect Dis 2007; 13: 1769-1772.
15. Strupp M. News on multiple sclerosis: induction of immune tolerance a biomarker for predicting disease activity, and CSF ferritin levels. J Neurol 2010; 257: 2114-2116.
16. Gono T, Kawaguchi Y, Ozeki E, et al. Serum ferritin correlates with activity of anti-MDA5 antibody-associated acute interstitial lung disease as a complication of dermatomyositis. Mod Rheumatol 2011; 21: 223-227.
17. Emmenegger U, Schaer DJ, Larroche C, Neftel KA. Haemophagocytic syndromes in adults: current concepts and challenges ahead. Swiss Med Wkly 2005; 135: 299-314.
18. Meijvis SC, Endeman H, Geers AB, ter Borg EJ. Extremely high serum ferritin levels as diagnostic tool in adult-onset Still's disease. Neth J Med 2007; 65: 212-214.
19. Janka G, zur Stadt U. Familial and acquired hemophagocy-tic lymphohistiocytosis. Hematology Am Soc Hematol Educ Program 2005: 82-88.
20. Tasdelen Fisgin N, Fisgin T, et al. Crimean-Congo hemorrhagic fever: five patients with hemophagocytic syndrome. Am J Hematol 2008; 83: 73-76.
21. Barut S, Dincer F, Sahin I, Ozyurt H, Akkus M, Erkorkmaz U. Increased serum ferritin levels in patients with Crimean-Congo hemorrhagic fever: can it be a new severity criterion? Int J Infect Dis 2010; 14: e50-e54.
22. Ozkurt Z, Ozden K, Karaca C, Parlac M. Serum ferritin levels and relation with clinical severity in patients with Crimean Congo hemorrhagic fever.3.Eurasia Congress of Infectious Diseases (EACID).1-4 October 2009, Baku, Azerbaijan, Oral Presentation No: O-14.
23. Kumar R, Indrayan A. Receiver operating characteristic (ROC) curve for medical researchers. Indian Pediatr 2011; 48: 277-287.
24. Papa A, Bino S, Velo E, Harxhi A, Kota M, Antoniadis A. Cytokine levels in Crimean-Congo hemorrhagic fever. Jour Clin Virol 2006; 36: 272-276.
25. Ozkurt Z, Kiki I, Erol S, et al. Crimean-Congo hemorrhagic fever in Eastern Turkey: Clinial features, risk factors and efficacy of ribavirin therapy. J Infection 2006; 52: 207-215.
26. Bakhtiari K, Meijers JC, de Jonge E, Levi M. Prospective validation of the International Society of Thrombosis and Haemostasis scoring system for disseminated intravascular coagulation. Crit Care Med 2004; 32: 2416-2421.
27. Ergönül O, Celikbaş A, Dokuzoguz B, Eren S, Baykam N, Esener H. Characteristics of patients with Crimean-Congo hemorrhagic fever in a recent outbreak in Turkey and impact of oral ribavirin therapy. Clin Infect Dis 2004; 39: 284-287.
28. Henter JI, Horne A, Arico M, et al. HLH-2004: Diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer 2007; 48: 124-131.
29. Karti SS, Odabasi Z, Korten V, et al. Crimean-Congo hemorrhagic fever in Turkey. Emerg Infect Dis 2004; 10: 1379-1384.